Gil Kristen 4

What Happened

• Gil Kristen, a director of UnitedHealth Group (UNH), received an award/acquisition of 8 shares on 2026-03-17. The filing reports the shares were issued at $0.00 (total reported value $0), representing dividend equivalents paid on vested deferred stock units rather than a cash purchase.

Key Details

• Transaction date and type: 2026-03-17 — Award/Acquisition (code A)
• Price: $0.00 per share; total reported value $0
• Shares owned after transaction: not specified in the Form 4 filing
• Footnote: F1 — these 8 shares represent dividend equivalents paid on vested deferred stock units; the dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units
• Filing: Form 4 filed 2026-03-19 reporting the 3/17 transaction

Context

• This was an award of dividend equivalents on deferred stock units (compensation-related), not an open-market purchase or sale. Such awards are routine compensation items and do not by themselves indicate a change in the insider's market view.